Global Wellness Times
SEE OTHER BRANDS

Global take on healthcare and wellness news

Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on May 7, 2025

STERIS Declares Dividend of $0.57 per share

STERIS Declares Dividend of $0.57 per share

DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on June 26, 2025, to shareholders …

Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology

Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology

SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) --  Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced today that JCO Precision Oncology published a real-world study suggesting that the results of …

DLH Reports Fiscal 2025 Second Quarter Results

DLH Reports Fiscal 2025 Second Quarter Results

ATLANTA, May 07, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to …

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

— Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) on track for the second half of 2025     — Streamlining operations and focusing on delivering potential value generating program milestones, with …

PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania’s Largest Solar Projects

PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania’s Largest Solar Projects

TEL AVIV, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced the launch of a strategic pilot program with Econergy Renewable Energy Ltd., a leading European independent power producer (IPP). The project will utilize …

Beyond Meat® Announces $100 Million New Senior Secured Financing from Ahimsa Foundation Affiliate

Beyond Meat® Announces $100 Million New Senior Secured Financing from Ahimsa Foundation Affiliate

EL SEGUNDO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or the “Company”), a leader in plant-based meat, today announced it has successfully closed on a financing facility providing up to $100 million in new …

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Catalyst Enters 2025 With Strong Momentum; Reiterates Confidence in Full-Year Outlook Delivers Record Q1 2025 Total Revenues of $141.4 Million, a 43.6% YoY Increase FIRDAPSE® and AGAMREE® Drive Sustained Organic Growth, Underscoring Execution Strength …

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …

SkinBliss Skin Tag Remover Under Review: The Super Luxe Skin Tag Remover for Derma Clear Support

SkinBliss Skin Tag Remover Under Review: The Super Luxe Skin Tag Remover for Derma Clear Support

New York, May 07, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: What skin tags are and why they form on the body The major pain points associated with skin tags,including cosmetic and comfort concerns Why conventional skin tag removal methods …

Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update

Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update

- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC phase 2 trial ongoing with clinical data update at 2025 ASCO® Annual Meeting - Based on the Company’s current operating plan, existing cash, cash equivalents and marketable securities …

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents

Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); May 7, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires

GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …

Inspirato Reports Record Q1 Profitability and Reiterates Full Year Guidance

Inspirato Reports Record Q1 Profitability and Reiterates Full Year Guidance

DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato” or the “Company”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today reported results for the first quarter (“Q1 2025”) ended March 31, 2025. …

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …

Brisbane Based Ian Lazar Digital Commence Features On Latest Medical and Dental Devices

Brisbane Based Ian Lazar Digital Commence Features On Latest Medical and Dental Devices

Leading Sydney Lifestyle Magazine Ian Lazar Digital confirmed commencing featured posts focusing the work of Australian medical and Dental supply companies. BRISBANE, QLD, AUSTRALIA, May 7, 2025 /⁨EINPresswire.com⁩/ -- Ian Lazar Digital is an online …

The Honest Company Reports First Quarter 2025 Results

The Honest Company Reports First Quarter 2025 Results

Achieves Quarterly Revenue of $97 Million, an Increase of 13% from Prior Year Quarter Delivers Net Income of $3 Million and Expands Gross Margin 170 Basis Points to 39% from Prior Year Quarter Reaffirms Full Year 2025 Financial Outlook LOS ANGELES, May 07, …

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

-  Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA -  Lead target and portfolio strategy to be announced mid …

InnovAge Earns Recertification as a Great Place to Work

InnovAge Earns Recertification as a Great Place to Work

DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- InnovAge, a leading provider of Program of All-Inclusive Care for the Elderly (PACE) services, is proud to announce its recertification as a Great Place to Work®. This recognition reflects the company’s continued …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service